NEW YORK (GenomeWeb News) – Rutgers University and Carestream Molecular Imaging today announced the signing of a two-year collaborative agreement that provides the university with a PET/CT imaging platform, computer systems, and software.

As part of the deal, Rutgers and Carestream will partner on product awareness, the exchange of scientific knowledge, and new product development. The new Molecular Imaging Center at the university will also serve as a user demonstration site.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.